Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$35.41 USD
+0.43 (1.23%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $35.44 +0.03 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/29/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 0.00% |
ABR | 1.53 |
Earnings ESP
|
-6.14% |
---|---|
Current Year | -1.08 |
Next Year | 0.79 |
EPS (TTM) | -3.46 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 191.98M | 214.29M | 811.57M | 1.12B |
# of Estimates | 9 | 9 | 9 | 8 |
High Estimate | 230.15M | 262.77M | 961.14M | 1.37B |
Low Estimate | 180.27M | 195.36M | 765.90M | 952.10M |
Year ago Sales | 94.97M | 110.40M | 396.59M | 811.57M |
Year over Year Growth Est. | 102.14% | 94.10% | 104.64% | 38.52% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.19 | -1.08 | 0.79 |
# of Estimates | 11 | 9 | 11 | 10 |
Most Recent Consensus | -0.36 | -0.32 | -1.42 | 0.86 |
High Estimate | 0.06 | 0.26 | 0.35 | 2.67 |
Low Estimate | -0.42 | -0.34 | -1.50 | -0.88 |
Year ago EPS | -1.02 | -1.17 | -4.45 | -1.08 |
Year over Year Growth Est. | 69.61% | 83.76% | 75.73% | 172.96% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 0 |
Up Last 30 Days | 2 | 1 | 2 | 1 |
Up Last 60 Days | 6 | 6 | 8 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 2 |
Down Last 30 Days | 0 | 0 | 0 | 2 |
Down Last 60 Days | 1 | 2 | 2 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.19 | -1.08 | 0.79 |
7 Days Ago | -0.32 | -0.19 | -1.10 | 0.82 |
30 Days Ago | -0.33 | -0.21 | -1.15 | 0.79 |
60 Days Ago | -0.37 | -0.25 | -1.27 | 1.04 |
90 Days Ago | -0.39 | -0.28 | -1.36 | 1.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.33 | -0.09 | -1.06 | 0.47 |
Zacks Consensus Estimate | -0.31 | -0.19 | -1.08 | 0.79 |
Earnings ESP | -6.14% | 51.79% | 1.85% | -40.36% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.73 | -1.17 | -1.02 | NA |
Estimate | -0.54 | -0.66 | -0.84 | -1.35 | NA |
Difference | 0.00 | -0.07 | -0.33 | 0.33 | -0.02 |
Surprise | 0.00% | -10.61% | -39.29% | 24.44% | -6.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more